secwatch.observer — SEC 8-K summary
======================================

Issuer:     AGILENT TECHNOLOGIES, INC. (A)
CIK:        0001090872
Form:       8-K
Filed at:   2024-09-03T23:59:59+00:00
Accession:  0001090872-24-000036
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Agilent recasts segment financials moving cell analysis to diagnostics and genomics
--------------------------------------------------------------------------------

- Move of cell analysis from life sciences/applied markets to diagnostics/genomics segment effective Q1 FY2024.
- Historical FY2023 data recast in Exhibit 99.1; three reportable segments unchanged.
- No change to Agilent CrossLab segment; recast for comparability only.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1090872/000109087224000036/0001090872-24-000036-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1090872/000109087224000036/a-20240903_d2.htm
  HTML page:      https://secwatch.observer/filing/0001090872-24-000036

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer